Creating a Circular Economy for the Pharmaceutical Packaging Industry

What is the Factory of the Future? It is a vision of a holistic company-wide transformation, which balances and combines: productivity, quality, and robustness based on a data-centric perspective. Is it possible to build the Pharma Factory of the Future today, increase quality and productivity, and decrease the cost at the same time?

The clinical development marketplace continues to become more complex and competitive, with stricter regulatory standards and trial oversight—all the while demanding patient-centric drug development. These, and other factors, contribute to unsustainable costs and longer timelines before much-needed therapies reach the market.

This webinar will benefit executives at Biotech and Pharmaceutical companies interested in learning more about 505(b)(2) drug development and how to save time and money while maximizing the value of their drug development program.

Join this webinar to discover the advantages of using Signatura™ (RUO), a novel assay custom-designed for each patient that detects circulating tumour DNA (ctDNA) with high sensitivity and specificity to monitor molecular residual disease, early recurrence, and treatment response across solid tumours. Learn about the latest clinical data for Signatura and explore how this unique ctDNA assay can be applied in pharmaceutical development and oncology clinical study design, potentially increasing the probability of trial success, reduce the time to trial readout, and decrease clinical trial costs